EIM
XLRN

Essex Investment Management’s Acceleron Pharma XLRN Stock Holding History

Essex Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,364
Closed -$284K – 389
2014
Q2 		$284K Sell
8,364
-3,094
-27% -$103K 0.04% 308
2014
Q1 		$395K Buy
+11,458
New +$517K 0.06% 268

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Essex Investment Management's XLRN Position: Q3 2014 in Review

Essex Investment Management sold out of Acceleron Pharma (XLRN) in Q3 2014, closing a stake of 8,364 shares — an estimated $284K sold.

Essex Investment Management first reported a position in XLRN in Q1 2014 and held it in 2 quarters. The position peaked at $395K in Q1 2014. 84 funds tracked by Wall St. Rank hold XLRN as of Q3 2014.

  • Essex Investment Management reported no remaining Acceleron Pharma position as of Q3 2014 after selling out during the quarter.
  • Essex Investment Management sold 8,364 Acceleron Pharma shares in Q3 2014, an estimated $284K.
  • Essex Investment Management first reported a position in Acceleron Pharma in Q1 2014 and held it in 2 quarters.
  • Essex Investment Management's Acceleron Pharma position peaked at $395K in Q1 2014.
  • 84 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2014.

Based on Essex Investment Management's 13F filing for Q3 2014, filed 29 Oct 2014.